Finance

Lists
531146:BOM
Medicamen Biotech Ltd
₹296,95
-1,95%
(-5,90) 1D
15 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 531146...
Open
₹298,20
High
₹298,20
Low
₹295,00
Mkt. cap
4,00 mjd
Avg. vol.
5,75 k
Volume
272,00
Dividend
0,34%
Quarterly dividend
₹0,25
Ex-dividend date
18 Sep. 2026
P/E ratio
34,20
52-wk high
₹454,00
52-wk low
₹210,10
EPS
₹8,68
Shares outstanding
11,70 m
No. of employees
405
Open
₹298,20
High
₹298,20
Low
₹295,00
Mkt. cap
4,00 mjd
Avg. vol.
5,75 k
Volume
272,00
Dividend
0,34%
Quarterly dividend
₹0,25
Ex-dividend date
18 Sep. 2026
P/E ratio
34,20
52-wk high
₹454,00
52-wk low
₹210,10
EPS
₹8,68
Shares outstanding
11,70 m
No. of employees
405
News stories
From web sources and news partners
About Medicamen Biotech Ltd
CEO-
Employees405
Founded1993
Headquarters-
SectorPharmaceutical industry
Websitemedicamen.com
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
475,43 m
474,43 m
592,69 m
487,58 m
Cost of goods sold
231,53 m
237,10 m
349,40 m
211,20 m
Cost of revenue
231,53 m
237,10 m
349,40 m
211,20 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
88,31 m
83,73 m
146,78 m
93,14 m
Operating expense
207,18 m
206,51 m
219,99 m
242,38 m
Total operating expenses
438,71 m
443,61 m
569,39 m
453,58 m
Operating income
36,72 m
30,83 m
23,30 m
34,01 m
Other non operating income
-
1,00 k
8,26 m
-
EBT including unusual items
26,83 m
21,11 m
50,60 m
25,72 m
EBT excluding unusual items
26,83 m
21,11 m
50,56 m
25,72 m
Income tax expense
5,69 m
4,76 m
6,13 m
7,26 m
Effective tax rate
21,19%
22,56%
12,11%
28,22%
Other operating expenses
100,30 m
104,51 m
55,88 m
131,37 m
Net income
26,67 m
21,87 m
37,39 m
21,18 m
Net profit margin
5,61%
4,61%
6,31%
4,34%
Earnings per share
-
-
-
-
Interest and investment income
-
-
17,39 m
-
Interest expense
-9,89 m
-9,72 m
-3,83 m
-8,29 m
Net interest expenses
-9,89 m
-9,72 m
13,56 m
-8,29 m
Depreciation and amortization charges
18,57 m
18,27 m
17,33 m
17,87 m
EBITDA
55,01 m
48,10 m
40,92 m
52,05 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme